Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?

por Dong Lin, Dong Lin, Yequn Chen, Yequn Chen, Yequn Chen, Jian Yong, Shiwan Wu, Yan Zhou, Weiping Li, Weiping Li, Xuerui Tan, Xuerui Tan, Xuerui Tan, Ruisheng Liu
Publicado 2021